Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02272790
Title Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications

ovary epithelial cancer

fallopian tube cancer

peritoneum cancer

Therapies

Adavosertib + Pegylated liposomal-doxorubicin

Adavosertib + Carboplatin

Adavosertib + Gemcitabine

Adavosertib + Paclitaxel

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.